Atlas Trials

PIK3CA Mutant Metastatic Breast Cancer

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch PIK3CA Mutant Metastatic Breast Cancer

RecordFirmDate
Alpelisib (BYL719) in Combination With Continued Endocrine Therapy Following Progression on Endocrine Therapy in Hormone Receptor Positive, HER2 Negative, PIK3CA Mutant Metastatic Breast Cancer (NCT04762979)Marina N Sharifi2021-02-12

Track PIK3CA Mutant Metastatic Breast Cancer automatically

Every clearance here is in the API, with alerts when new ones post.